These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 36441069

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer.
    Asad D, Styrke J, Hagsheno M, Johansson M, Huge Y, Svensson J, Pelander S, Lauer J, Netterling H, Aljabery F, Sherif A.
    Scand J Urol; 2022 Feb; 56(1):20-26. PubMed ID: 34806518
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M, European Association of Urology.
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Hagen F, Norz V, Thaiss WM, Mair A, Rausch S, Bedke J, Nikolaou K, Stenzl A, Kruck S, Hepp T, Kaufmann S, Estler A.
    Eur J Radiol; 2022 Jan; 146():110059. PubMed ID: 34839167
    [Abstract] [Full Text] [Related]

  • 31. The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
    Carando R, Afferi L, Marra G, Krajewski W, Pagliarulo V, Abufaraj M, Xylinas E, Cathelineau X, Sanchez-Salas R, Moschini M.
    Arab J Urol; 2020 Mar 01; 18(2):67-71. PubMed ID: 33029409
    [Abstract] [Full Text] [Related]

  • 32. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P, Johnston A, Padovani L, Clark E, Trail M, Hamid S, Hollins G, Simpson H, Thomas BG, Hasan R, Bhatt J, Ahmad I, Nandwani GM, Mitchell IDC, Hendry D, for members of the Scottish Bladder Cancer QPI Research Collaborative.
    Eur Urol; 2020 Oct 01; 78(4):520-530. PubMed ID: 32690321
    [Abstract] [Full Text] [Related]

  • 33. Preoperative imaging for locoregional staging of bladder cancer.
    Mirmomen SM, Shinagare AB, Williams KE, Silverman SG, Malayeri AA.
    Abdom Radiol (NY); 2019 Dec 01; 44(12):3843-3857. PubMed ID: 31377833
    [Abstract] [Full Text] [Related]

  • 34. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Arita Y, Shigeta K, Akita H, Suzuki T, Kufukihara R, Kwee TC, Ishii R, Mikami S, Okuda S, Kikuchi E, Oya M, Jinzaki M.
    Eur Radiol; 2021 Feb 01; 31(2):875-883. PubMed ID: 32829418
    [Abstract] [Full Text] [Related]

  • 35. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T.
    BJU Int; 2012 Dec 01; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [Abstract] [Full Text] [Related]

  • 36. Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
    Eulitt PJ, Altun E, Sheikh A, Wong TZ, Woods ME, Rose TL, Wallen EM, Pruthi RS, Smith AB, Nielsen ME, Whang YE, Kim WY, Godley PA, Basch EM, David GU, Ramirez J, Deal AM, Rathmell WK, Chen RC, Bjurlin MA, Lin W, Lee JK, Milowsky MI.
    Clin Genitourin Cancer; 2020 Oct 01; 18(5):378-386.e1. PubMed ID: 32147364
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic performance of multiparametric MRI based Vesical Imaging-Reporting and Data System (VI-RADS) scoring in discriminating between non-muscle invasive and muscle invasive bladder cancer.
    Islam NU, Jehangir M, Parry AH, Nazir SS, Bilal S.
    Pol J Radiol; 2023 Oct 01; 88():e356-e364. PubMed ID: 37701172
    [Abstract] [Full Text] [Related]

  • 38. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.
    Franklin A, Yaxley WJ, Raveenthiran S, Coughlin G, Gianduzzo T, Kua B, McEwan L, Wong D, Delahunt B, Egevad L, Samaratunga H, Brown N, Parkinson R, Roberts MJ, Yaxley JW.
    BJU Int; 2021 Jan 01; 127(1):71-79. PubMed ID: 32524748
    [Abstract] [Full Text] [Related]

  • 39. Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.
    Arita Y, Woo S, Kwee TC, Shigeta K, Ueda R, Nalavenkata S, Edo H, Miyai K, Das J, Andrieu PIC, Vargas HA.
    Abdom Radiol (NY); 2024 Aug 01; 49(8):2797-2811. PubMed ID: 38847848
    [Abstract] [Full Text] [Related]

  • 40. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS.
    Noh TI, Shim JS, Kang SG, Sung DJ, Cheon J, Sim KC, Kang SH.
    Sci Rep; 2022 Nov 30; 12(1):20689. PubMed ID: 36450813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.